iifl-logo
  • testing
  • |

iifl-logo

Piramal Pharma Ltd Board Meeting

206.07
(-2.35%)
Jun 10, 2025|12:00:00 AM

Piramal Pharma CORPORATE ACTIONS

02/07/2024calendar-icon
02/07/2025calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting14 May 202529 Apr 2025
Piramal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2025 inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the financial year ended 31st March 2025 and to consider recommending payment of dividend to the shareholders. Please refer attachment (As Per BSE Announcement dated on 14.05.2025)
Board Meeting28 Jan 202513 Jan 2025
Piramal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2025 inter alia to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 31st December 2024 Outcome of Board Meeting of Piramal Pharma Limited (Company) held on 28th January 2025. (As Per Bse Announcement Dated on 28.01.2025)
Board Meeting23 Oct 202414 Oct 2024
Piramal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2024 inter alia to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September 2024 Please refer attachment (As per BSE Announcement Dated on 23/10/2024)
Board Meeting30 Sep 202430 Sep 2024
Intimation of Press Release announcing capacity expansion plan approved at the meeting of the Administrative Committee of the Board, today, on 30th Sept, 2024
Board Meeting26 Jul 202415 Jul 2024
Piramal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2024 inter alia to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th June 2024 As per attachment. (As Per BSE Announcement dated on 26.07.2024)

Piramal Pharma: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

testing
  • testing
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

testing
  • testing
  • testing

ATTENTION INVESTOR

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.